SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

The TRUMP crypto token is currently facing intense scrutiny and volatility as the community debates a sharp decline in value alongside controversies surrounding exclusive gala luncheons restricted to top holders. Investors are actively discussing the project's long-term utility versus its reputation as a speculative grift, with sentiment deeply divided between loyal supporters and critics highlighting all-time lows.

"What's Updog?" is a Community Led token.

UpDog

UpDog is generating significant social media buzz as a long-standing Solana-based memecoin that emphasizes community resilience and a humorous "dad joke" meta. Investors are actively discussing whale accumulation and a "together we win" sentiment as they promote the token's presence on major decentralized exchange aggregators.

Chip

CHIP is capturing significant retail attention following its broad availability on major trading platforms and its positioning as a governance token for AI-focused infrastructure. While many investors are expressing excitement over its potential as a long-term utility play, the community remains divided as others express skepticism, frequently labeling it a pump-and-dump scheme due to high supply dilution concerns and sharp price volatility.

Index Coop is a decentralized autonomous organization (DAO) that builds structured DeFi products and strategy tokens. Index Coop offers a suite of sector index products, leverage and inverse products, and yield-generating products. The product suite runs on Set Protocol, an audited, self-custodial DeFi tool that allows for the creation and management of Ethereum-based (or ERC-20) tokens. Changes to the DAO are voted on by the owners of a governance token called INDEX and then implemented by a team of developers. INDEX holders wield voting power on a 1:1 basis, meaning one token equals one vote.

Index Cooperative

Index Cooperative is seeing heightened community engagement driven by its low circulating supply and status as a micro-cap DeFi token, with many users speculating on its potential for significant volatility. Investors are actively debating the token's long-term utility while tracking technical indicators and potential accumulation patterns in hopes of an upcoming breakout.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to heightened volatility and intense debate among investors regarding its potential for a short squeeze, driven by significant short interest and anticipation surrounding upcoming data catalysts for its lead asset, soquelitinib. The community is sharply divided, with bulls pointing to institutional accumulation and clinical potential in oncology and immunology, while bears emphasize the speculative nature of early-stage trials and the risks of future dilution.

Orca is the most user-friendly DEX on Solana.  Orca is one of the first general-purpose AMMs launched on Solana. Users can swap assets, provide liquidity, and earn yield through an easy-to-use interface. Projects can use Orca as a money-lego to easily integrate swapping, farming, or on-chain data into their dApp.  Orca strives to provide easy and effective financial tools for everyone, bringing DeFi to the masses.

Orca

Orca is seeing intense trading volume and bullish sentiment driven by its role as a leading Solana DEX, with community members actively discussing potential short squeezes and the impact of broader ecosystem growth. Investors are focused on its concentrated liquidity features and upcoming DAO governance proposals, while sentiment remains divided between those expecting a massive breakout and others warning of high volatility.

Pippin is an SVG unicorn drawn using the latest LLM benchmarks on ChatGPT 4o. It is an autonomous AI agent on X. Pippin was created by Yohei Nakajima, a recognised innovator and thought leader in the Al VC space (followed by Jeff Bezos and Marc Andreessen). He is known for his build-in-public approach and has been at the forefront of the ‘AI for VC’ movement, launching over 100+ AI-driven prototypes, automation agents &amp; open-source projects.  His most notable build is BabyAGI (March 2023), the first popular open-source autonomous agent with task-planning capability. The project went viral on Twitter amassing millions of impressions and resulting in tens of thousands of GitHub stars, dozens of Arxiv citations, coverage across major online media publications globally, and many speaker engagements including the inaugural TED AI in San Francisco.

pippin

PIPPIN is facing intense community scrutiny, with traders debating whether the asset is experiencing a genuine reversal or serving as a high-risk pump-and-dump scheme. Investors remain divided, with some actively attempting to short the coin while others point to its unusual volatility and centralized holder concentration as major red flags.

Dumb SEND IT

Dumb SEND IT ($DSIT) is gaining traction as investors rally behind a community-driven initiative that focuses on active participation and frequent token airdrops to build early momentum. The project's dedicated developer is maintaining an active presence to foster trust, while holders are encouraging others to accumulate during market dips to position themselves for potential future growth.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter is trending as the community highlights the project's long-standing presence on the Solana network, emphasizing its recent placement on the Jupiter Strict List. Investors are actively discussing community-driven engagement strategies and participation in the broader Solana meme coin ecosystem.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as investors focus on long-term utility, payment infrastructure, and rumors surrounding potential upcoming partnerships. The community remains deeply divided between long-term holders accumulating for projected growth and short-term traders debating its speculative performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tudor Investment Corp ET AL Acquires New Shares in Relay Therapeutics, Inc. $RLAY

Tudor Investment Corp ET AL acquired a new stake in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities...

Relay Therapeutics (NASDAQ:RLAY) Sets New 1-Year High - Should You Buy?

Relay Therapeutics (NASDAQ:RLAY) Reaches New 52-Week High - Time to Buy...

JonesTrading Initiates Coverage on Relay Therapeutics (NASDAQ:RLAY)

JonesTrading assumed coverage on Relay Therapeutics in a report on Tuesday. They set a "hold" rating and a $18.00 price objective on the stock...

Relay Therapeutics (NASDAQ:RLAY) CFO Thomas Catinazzo Sells 1,800 Shares

Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) CFO Thomas Catinazzo sold 1,800 shares of the company's stock in a transaction dated Thursday, April 9th. The stock was sold at an average price of $15.00, for a total value of $27,000.00. Following the completion of the sale, the chief...

Relay Therapeutics (NASDAQ:RLAY) CFO Sells $230,498.17 in Stock

Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) CFO Thomas Catinazzo sold 17,717 shares of Relay Therapeutics stock in a transaction dated Tuesday, April 7th. The shares were sold at an...

Thomas Catinazzo Sells 1,800 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock

Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) CFO Thomas Catinazzo sold 1,800 shares of Relay Therapeutics stock in a transaction dated Thursday, April 9th. The shares were sold at an...

Relay Therapeutics (NASDAQ:RLAY) Hits New 52-Week High on Analyst Upgrade

Relay Therapeutics (NASDAQ:RLAY) Reaches New 12-Month High After Analyst Upgrade...

Relay Therapeutics (NASDAQ:RLAY) Given New $21.00 Price Target at Barclays

Barclays lifted their price objective on shares of Relay Therapeutics from $17.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday...

JPMorgan Chase & Co. Reduces Position in Relay Therapeutics, Inc. $RLAY

JPMorgan Chase & Co. cut its holdings in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY - Free Report) by 89.3% during the 3rd quarter, according to its most recent Form 13F filing with the...

Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?

Relay Therapeutics (RLAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

Current Price	$15.13
Prev Close	$15.09
Open	$15.17
Dividend Yield	0.00%
50-Day Moving Average	$11.45
Beta	1.84
Avg. Volume	2.6M
PE Ratio	-9.38

52-Week High	$17.32
52-Week Low	$2.67
Market Capitalization	$2.86B
EPS (Annual)	-$1.61
Price to Book	4.64
Revenue Per Employee	$79,973.96

RLAY
Relay Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RLAY News

RLAYRelay Therapeutics Inc